Fina Biosolutions LLC is a biotech company located in Rockville, MD, specializing in the production and characterization of functionalized dextrans and related products. With expertise in polysaccharide conjugation, they offer a range of bioconjugation and protein services tailored to the needs of emerging market vaccine manufacturers, aiming to make affordable conjugate vaccines.
Founded in 2006 by Dr. Andrew Lees, Fina Biosolutions has grown to become a global provider of conjugate vaccine laboratory and consulting services for the Biotech and Vaccine industry. Their core focus lies in conjugation chemistry, bioconjugation, and conjugate vaccines, with a commitment to helping emerging markets in the production of affordable vaccines.
Generated from the website